Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimer’s disease in 2033.

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

This specifically involved distinguishing between Alzheimer's disease, the most common form of dementia, and Lewy body ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...

The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...